Pulmonx Corporation (LUNG) Financial Statements (2024 and earlier)

Company Profile

Business Address 700 CHESAPEAKE DRIVE
REDWOOD CITY, CA 94063
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments83,54794,945135,152152,836141,138156,899
Cash and cash equivalents83,54794,945101,581110,407101,736112,402
Short-term investments   33,57142,42939,40244,497
Receivables13,02010,9209,8308,8459,2797,619
Inventory, net of allowances, customer advances and progress billings16,74316,13115,63615,58814,56415,568
Inventory16,74316,13115,63615,58814,56415,568
Prepaid expense2,8163,4023,2263,6513,4512,611
Other current assets504193118147290183
Other undisclosed current assets33,79221,773466231231231
Total current assets:150,422147,364164,428181,298168,953183,111
Noncurrent Assets
Inventory, Noncurrent2,5803,4454,4344,7745,2834,559
Operating lease, right-of-use asset3,4064,0614,7065,1525,8066,406
Property, plant and equipment4,0284,0654,2184,4904,6944,922
Long-term investments and receivables   12,4542,6375,924 
Long-term investments   12,4542,6375,924 
Intangible assets, net (including goodwill)2,3642,3952,4252,4562,4872,518
Goodwill2,3332,3332,3332,3332,3332,333
Intangible assets, net (excluding goodwill) 316292123154185
Other noncurrent assets591415448465529687
Other undisclosed noncurrent assets14,39023,271    
Total noncurrent assets:27,35937,65228,68519,97424,72319,092
TOTAL ASSETS:177,781185,016193,113201,272193,676202,203
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities17,73116,87315,93913,52215,03421,135
Taxes payable573
Employee-related liabilities7,170
Accounts payable1,4973,1892,3772,8901,7582,648
Accrued liabilities16,23413,68413,56210,63213,27610,744
Deferred revenue1048595107120106
Debt2,155919391905,043
Other undisclosed current liabilities3,1673,4363,3943,3593,248(4,598)
Total current liabilities:23,15720,48519,52117,07918,49221,686
Noncurrent Liabilities
Long-term debt and lease obligation35,08937,15437,14737,173 16,984
Long-term debt, excluding current maturities35,08937,15437,14737,173 12,340
Liabilities, other than long-term debt1,2201,6342,4933,0863,94351
Deferred income tax liabilities1149794719451
Operating lease, liability1,1061,5372,3993,0153,8494,644
Other undisclosed noncurrent liabilities     17,234 
Total noncurrent liabilities:36,30938,78839,64040,25921,17717,035
Total liabilities:59,46659,27359,16157,33839,66938,721
Equity
Equity, attributable to parent118,315125,743133,952143,934154,007163,482
Common stock393838383837
Additional paid in capital526,797521,034514,331508,254502,712498,083
Accumulated other comprehensive income2,6401,9441,9561,8201,5751,397
Accumulated deficit(411,161)(397,273)(382,373)(366,178)(350,318)(336,035)
Total equity:118,315125,743133,952143,934154,007163,482
TOTAL LIABILITIES AND EQUITY:177,781185,016193,113201,272193,676202,203

Income Statement (P&L) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Revenues19,27817,66817,19414,53515,42513,502
Cost of revenue
(Cost of Goods and Services Sold)
(4,878)(4,639)(4,460)(3,946)(4,241)(3,350)
Gross profit:14,40013,02912,73410,58911,18410,152
Operating expenses(28,319)(28,205)(29,173)(26,989)(25,811)(24,083)
Operating loss:(13,919)(15,176)(16,439)(16,400)(14,627)(13,931)
Nonoperating income1,1841,2281,2481,23594945
Investment income, nonoperating1,5411,4901,4101,127748477
Other nonoperating income (expense)(357)(262)(162)108201(432)
Interest and debt expense(905)(893)(864)(571)(359)(286)
Loss from continuing operations before income taxes:(13,640)(14,841)(16,055)(15,736)(14,037)(14,172)
Income tax expense(248)(59)(140)(124)(246) 
Loss from continuing operations:(13,888)(14,900)(16,195)(15,860)(14,283)(14,172)
Loss before gain (loss) on sale of properties:(14,172)
Net loss available to common stockholders, diluted:(13,888)(14,900)(16,195)(15,860)(14,283)(14,172)

Comprehensive Income ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Net loss:(13,888)(14,900)(16,195)(15,860)(14,283)(14,172)
Comprehensive loss:(13,888)(14,900)(16,195)(15,860)(14,283)(14,172)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent696(12)13624517840
Comprehensive loss, net of tax, attributable to parent:(13,192)(14,912)(16,059)(15,615)(14,105)(14,132)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: